1. A safety inlet apparatus for a paper feed opening of a shredder, comprising:
an upper cover having a paper feed passage with a passage entrance and having an upper cover inner wall, and
a safety cover having a first end section and a second end section, the safety cover being rotatably coupled to the upper cover, wherein the safety cover first end section is rotatable to cover the passage entrance,
a paper feed passage block connected to the second section, slidably arranged on the upper cover toward paper feed passage, and limiting safety cover movement; and
an elastic member having ends respectively connected to the upper cover inner wall of said and to said paper feed passage block, wherein movement of the elastic member resiliently actuates the safety cover to rotate toward closure of the passage entrance.
2. The safety inlet apparatus according to claim 1, wherein the paper feed passage block is fixed to the second end section.
3. The safety inlet apparatus, according to claim 1, wherein the paper feed passage block is integrated with the second end section.
4. The safety inlet apparatus according to claim 1, wherein paper feed passage block is disposed between the paper feed passage and the elastic member.
5. The safety inlet apparatus according to claim 4, wherein the elastic member comprises a tension spring.
6. The safety inlet apparatus according to claim 1, wherein at least one stud is provided on the second end section, and wherein the at least one stud is limited by the paper feed passage block.
7. The safety inlet apparatus according to claim 1, wherein the safety cover is pivotably coupled to the upper cover.
8. The safety inlet apparatus according to claim 7, further comprising:
rotating axles provided on sides of the safety cover;
axle seats facingly disposed on the upper cover,
wherein the axel seats are positioned to receive a respective rotating axel, and wherein the rotating axels of the safety cover are respectively mounted in the axle seats.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
What is claimed:
1. A method of treating migrainous headaches, comprising administering an aqueous composition comprising parthenolide sublingually to a patient in need thereof in a total administered amount of from about 0.05 mg to about 1.0 mg of parthenolide in a two hour period.
2. The method of claim 1, wherein said total administered amount is from about 0.05 mg to about 0.7 mg of parthenolide in a two hour period.
3. A method of treating migrainous headaches, comprising administering an aqueous composition comprising parthenolide sublingually to a patient in need thereof in a total administered amount of from about 0.05 mg to about 1.0 mg of parthenolide in a 24 hour period.
4. The method of claim 3, wherein the parthenolide is administered in at least two doses, and wherein each individual dose of parthenolide does not exceed about 0.20 mg.
5. The method of claim 1, wherein said composition additionally comprises ginger extract.
6. The method of claim 5, wherein said ginger extract is administered at a total administered amount not exceeding about 250 mg of ginger extract in a two hour period.
7. The method of claim 1, wherein said composition additionally comprises green tea extract.
8. The method of claim 1, wherein said composition additionally comprises L-theanine.
9. The method of claim 8, wherein said L-theanine is administered at a total administered amount not exceeding about 400 mg in a two hour period
10. A method of treating migrainous headaches, comprising administering an aqueous composition comprising feverfew extract sublingually to a patient in need thereof in a total administered amount of from about 4 mg to about 40 mg of feverfew extract in a two hour period.
11. The method of claim 10, wherein said total administered amount is from about 4 mg to about 20 mg of feverfew extract in a two hour period.
12. The method of claim 10, wherein said the feverfew extract has a standardized parthenolide concentration of from about 1.2% to about 10%.
13. A method of treating migrainous headaches, comprising administering an aqueous composition comprising feverfew extract sublingually to a patient in need thereof in a total administered amount of from about 4 mg to about 40 mg of feverfew extract in a 24 hour period.
14. The method of claim 13, wherein the feverfew extract is administered in at least two doses, and wherein each individual dose of feverfew extract does not exceed about 10 mg.
15. The method of claim 1, wherein said composition additionally comprises a mucosal permeation enhancer
16. The method of claim 1, wherein said composition has a pH of from about 2 to about 6.
17. The method of claim 1, wherein said composition has a pH of from about 3.0 to about 6.0.
18. The method of claim 1, wherein said composition contains substantially no active ingredients other than those that are extractable from herbal sources.
19. The method of claim 1, wherein said composition contains substantially no active ingredients other than those that are extractable from feverfew, ginger and green tea sources.
20. The method of claim 18, wherein said composition contains less than about 400 mg of any given natural active ingredient per dose.
21. The method of claim 10, wherein said composition comprises
0.05-10.0% feverfew extract,
0.1-10.0% ginger extract,
0.1-10.0% L-theanine, and
10-98% water.
22. The method of claim 21, wherein said composition further comprises
0.05-5% ascorbic acid and
0.05-5% sodium lauryl sulfate.
23. The method of claim 1, wherein said total administered amount is divided among a plurality of composition, and said plurality of compositions are administered sequentially.
24. The method of claim 1, wherein said composition is held sublingually for at least about 30 seconds prior to swallowing.
25. The method of claim 21, wherein said composition is circulated about the mouth prior to swallowing.
26. A unit dose applicator and liquid composition for sublingual treatment of patients, comprising
a) a dispenser for dispensing liquids, said dispenser having a reservoir and a delivery spout, said dispenser having a liquid capacity of about 0.1 to about 10 mls, and
b) an aqueous liquid composition disposed within said dispenser, said composition comprising parthenolide in an amount of from about 0.05 mg to about 1.0 mg.
27. A unit dose applicator and liquid composition for sublingual treatment of patients, comprising
a) a dispenser for dispensing liquids, said dispenser having a reservoir and a delivery spout, said dispenser having a liquid capacity of about 0.1 to about 10 mls, and
b) an aqueous liquid composition disposed within said dispenser, said composition comprising feverfew extract in an amount of from about 4 mg to about 40 mg.
28. The unit dose applicator and composition of claim 26, wherein said liquid composition additionally comprises ginger extract.
29. The unit dose applicator and composition of claim 26, wherein said liquid composition additionally comprises L-theanine.
30. The unit dose applicator and composition of claim 26, wherein said liquid composition comprises
0.05-10.0% feverfew extract,
0.1-10.0% ginger extract,
0.1-10.0% L-theanine, and
10-98% water.
31. The unit dose applicator and composition of claim 30, wherein said composition further comprises
0.05-5% ascorbic acid and
0.05-5% sodium lauryl sulfate.
32. The unit dose applicator and composition of claim 26, wherein said dispenser has a liquid capacity of about 1 to about 3 mls.
33. A liquid composition for treatment of patients comprising parthenolide in an amount of from about 0.01 mgml to about 0.25 mgml.
34. A liquid composition for treatment of patients comprising feverfew extract in an amount of from about 1 mgml to about 10 mgml.
35. The liquid composition of claim 33, wherein said liquid composition additionally comprises ginger extract.
36. The liquid composition of claim 33, wherein said liquid composition contains substantially no active ingredients other than those that are extractable from herbal sources.
37. The liquid composition of claim 33, wherein said liquid composition contains substantially no active ingredients other than those that are extractable from feverfew, ginger and green tea sources.
38. The liquid composition of claim 33, wherein said liquid composition additionally comprises a thickening agent.
39. The liquid composition of claim 33, wherein said liquid composition additionally comprises a mucosal permeation enhancer.
40. The liquid composition of claim 33, wherein said liquid composition has a pH of from about 2 to about 6.
41. The liquid composition of claim 34, wherein said liquid composition comprises
0.05-10.0% feverfew extract,
0.1-10.0% ginger extract,
0.1-10.0% L-theanine, and
10-98% water.
42. The liquid composition of claim 33, wherein said liquid composition has a viscosity from about 500 cP to about 5000 cP.
43. A method of treating hangovers, comprising administering an aqueous composition comprising parthenolide sublingually to a patient in need thereof in a total administered amount of from about 0.05 mg to about 1.0 mg of parthenolide in a two hour period.
44. A method of treating hangovers, comprising administering an aqueous composition comprising feverfew extract sublingually to a patient in need thereof in a total administered amount of from about 4 mg to about 40 mg of feverfew extract in a two hour period.